Skip to main content

6 Result(s)

within R Formankova Remove this filter

and

  1. No Access

    Article

    Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL

    Minimal residual disease (MRD) monitoring via quantitative PCR (qPCR) detection of Ag receptor gene rearrangements has been the most sensitive method for predicting prognosis and making post-transplant treatme...

    M Kotrova, V H J van der Velden, J J M van Dongen… in Bone Marrow Transplantation (2017)

  2. No Access

    Article

    Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donors

    Allogeneic HSCT is a curative treatment for high-risk leukemia. In Europe, approximately 15% of children have an HLA-matched sibling, but in 65–70% HLA allele-matched (9–10/10) unrelated donors (UD) can be ide...

    P Sedlacek, E Mejstrikova, R Formankova, P Keslova… in Bone Marrow Transplantation (2008)

  3. No Access

    Article

    B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL

    Minimal residual disease (MRD) detection using quantification of clone-specific Ig or TCR rearrangements before and after transplantation in children with high-risk ALL is an important predictor of outcome. Th...

    E Fronkova, K Muzikova, E Mejstrikova, M Kovac, R Formankova… in Bone Marrow Transplantation (2008)

  4. No Access

    Article

    Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin

    Human leukocyte antigen (HLA)-matched sibling donor hematopoietic stem cell transplantation (HSCT) is available for only approximately 30% patients needing HSCT. Use of alternative donors is associated with a ...

    P Sedláček, R Formánková, P Keslová, L Šrámková, P Hubáček… in Bone Marrow Transplantation (2006)

  5. No Access

    Article

    Do transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation?

    J Moravcová, S Nádvorníkova, Z Sieglová, R Formánková, L Krsková, R Dvořáková… in Leukemia (2001)

  6. No Access

    Article

    Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia

    We report a case of a 13-year-old boy who was transplanted for relapse of acute myeloid leukemia (AML). A detailed study of hematopoietic chimerism was performed using polymerase chain reaction (PCR) of variab...

    R Formánková, L Honzátková, Z Sieglová, J Starý, P Sedláček… in Bone Marrow Transplantation (2000)